Illumina Inc (ILMN) Company Profile & Statistics

Illumina Inc
ILMN
(Nasdaq - US)
N/A
104.22
+3.17 (+3.14%)
in:usd•As of: May 31, 2024 15:59 UTC -4
After Market:104.8+0.58 (+0.56%)
Open
100.92
High
104.32
Low
100.92

About Illumina Inc

CEO

Jacob Thaysen

Headquarters

5200 illumina way

san diego, ca 92122, united states

Auditor

Ernst & Young LLP

Employees

9,300

Share Holders

575

Website

www.illumina.com

Industry

biotechnology

Sector

health technology

Company Overview

Illumina Inc. is a life sciences company, which provides tools and integrated systems for analysis of genetic variation and function. Using its proprietary technologies, the company provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, and gene expression profiling of DNA and RNA. Its customers include leading genomic research centers, academic institutions, government laboratories, hospitals and reference laboratories as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic and consumer genomics companies. Illumina generates revenue from two segments - Product and Service. Product are primarily attributed to the partnerships and collaborations to develop distributable clinical in-vitro diagnostics for Illumina sequencers. Service include genotyping and sequencing services as well as instrument maintenance contracts.

Illumina Inc Statistics

Valuation Measures

Market Capitalization ²	16.60B
Enterprise Value	16.98B
Enterprise Value/EBITDA (ttm)	-24.87
Price to Earnings Ratio (ttm)	115.64
Price to Book (mrq)	2.83
Price to Sales (ttm)	3.61
Price to Cash (ytd)	28.40

Profitability

Gross Margin (ttm)	61.34%
Operating Margin (ttm)	3.07%
Profit Margin (ttm)	-28.67%
Return on Equity (ttm)	2.31%
Return on Invested Capital (ttm)	-17.29%
Return on Assets (ttm)	1.31%

Income Statement

Revenue (ttm)	4.49B
Revenue Per Share (ttm)	28.20
Gross Profit (ttm)	2.76B
EBITDA (ttm)³	-683.00M
Net Income Avi to Common (ttm)	-1.29B
Diluted EPS (ttm)	-8.15

Share Statistics

Beta (5Y Monthly)	1.20
52-Week Change	-47.65%
S&P500 52-Week Change	25.03%
S&P500 Member	Yes
Stock Optionable	Yes
Total Shares Outstanding ¹	159.30M
Dividend Yield	0.00%
Float ⁴	159.03M
% Held by Insiders	0.17%
% Held by Institutions	89.42%

Balance Sheet

Total Cash (mrq)	1.11B
Total Cash Per Share (mrq)	6.96
Total Debt (mrq)	1.49B
Total Debt/Equity (mrq)	25.99%
Current Ratio (mrq)	1.75%
Quick Ratio (mrq)	1.36%
Book Value Per Share (mrq)	36.06

Cash Flow

Operating Cash Flow Per Share (ytd)	0.48
Free Cash Flow (ytd)	41.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Illumina Inc

Trade With A Regulated Broker